Investors

Five things for pharma marketers to know: Wednesday, January 18, 2017

Five things for pharma marketers to know: Wednesday, January 18, 2017

By

Rep. Price to answer questions at confirmation hearing; 22 drugmakers invest in fighting disease in poor countries; FDA approves generic of Jazz's Xyrem

Five things for pharma marketers to know: Thursday, December 15, 2016

Five things for pharma marketers to know: Thursday, December 15, 2016

By

Drugmakers promote new type of opioid with unproven results; Heritage execs charged for price-fixing generics; Pershing sells more Valeant shares

Five things for pharma marketers to know: Monday, September 26, 2016

Five things for pharma marketers to know: Monday, September 26, 2016

By

Pfizer drops plans to split into two companies; Merck's Keytruda gains competitive edge in China; Apple may be developing health software

Editor's Desk: Escaping the Shkreli Cycle

Editor's Desk: Escaping the Shkreli Cycle

By

Three suggestions for defusing the highly charged pricing atmosphere

Five things for pharma marketers to know: Monday, June 15

Five things for pharma marketers to know: Monday, June 15

By

CVS Health to buy Target's pharmacy business; experimental gene therapy improves condition of teen with sickle-cell disease; PatientsLikeMe partners with the FDA to improve postmarket surveillance

OPINION

Email Newsletters